InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by McCubbin Quentin, Directeur de la fabrication. Officer active across 1 company, notably Frequency Therapeutics, Inc.. Cumulatively, 7 disclosures have been published. Breakdown: 2 buys · 3 sells. Total volume traded: €160k. History available since 17 May 2021. The latest transaction was disclosed on 18 February 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
17,500 sharesCommon StockSEC:0001127602-22-019049:0
1,411 shares@ US$3.8723.0% of flowCommon StockSEC:0001127602-22-006314:0
1,233 shares@ US$4.4293.0% of flowCommon StockSEC:0001127602-22-005747:0
1,233 shares@ US$4.4296.2% of flowCommon StockSEC:0001127602-22-005747
17,500 sharesCommon StockSEC:0001127602-22-005334:0
10,000 shares@ US$8.8545.5% of flowCommon StockSEC:0001127602-21-017370:0
Ideal exit: 11 Feb 2022 (T+270)
10,000 shares@ US$8.8545.5% of flowCommon StockSEC:0001127602-21-017370
Ideal exit: 11 Feb 2022 (T+270)
7 of 7 declarations
About McCubbin Quentin
Quentin McCubbin is the Chief Manufacturing Officer at Frequency Therapeutics, Inc. He is responsible for managing manufacturing operations, ensuring efficiency and product quality. His expertise in the sector enables him to contribute to optimizing production processes.
